Contact FreedomWorks

111 K Street NE
Suite 600
Washington, DC 20002

  • Toll Free 1.888.564.6273
  • Local 202.783.3870
LISTEN NOWConspiracies, Klobuchar, And Can't Adam Schiff Shut Up Already | Pardon The Disruption Listen Here
""
""
http://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/dope.jpg?itok=JuTXft2P
Blog

A Free Market Approach to Prescription Drugs

In his first State of the Union speech, President Trump once again promised to lower the swelling costs of prescription drugs. The question is – will the administration do it without imposing price controls.

02/06/2018
""
""
http://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/Biosimilar%20Drugs_1.jpg?itok=j-dffe0_
Blog

Bipartisan CREATES Act Will Lower Prescription Drug Costs

Sens. Chuck Grassley (R-Iowa) and Patrick Leahy (D-Vt.) reintroduced the CREATES Act, S. 974, in an effort to close regulatory loopholes at the Food and Drug Administration (FDA) that limit competition in the emerging market for biosimilars. Sen. Mike Lee and all of the other cosponsors of last year’s bill have returned as cosponsors. Rep. Tom Marino also introduced this bill in the House of Representatives on April 27th.

06/01/2017
""
""
http://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=35IWEBMb
Op-ed Placement

Biosimilars Bring Much-Needed Competition to Drug Markets

The high cost of medical care is one of the issues that most directly affect individuals and families. Historically, high initial investments in capital and a strict regulatory regime have effectively limited competition in many sectors of the medical industry. But thanks to advances in technology and a changing regulatory environment, some of that is starting to change.

11/23/2015